Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9272 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8961 |
High Similarity |
NPD7768 |
Phase 2 |
0.8882 |
High Similarity |
NPD4380 |
Phase 2 |
0.8828 |
High Similarity |
NPD1510 |
Phase 2 |
0.8805 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.88 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8701 |
High Similarity |
NPD7411 |
Suspended |
0.8681 |
High Similarity |
NPD1240 |
Approved |
0.8675 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8649 |
High Similarity |
NPD1549 |
Phase 2 |
0.8616 |
High Similarity |
NPD6959 |
Discontinued |
0.859 |
High Similarity |
NPD7819 |
Suspended |
0.8581 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD1607 |
Approved |
0.8544 |
High Similarity |
NPD7075 |
Discontinued |
0.8514 |
High Similarity |
NPD2796 |
Approved |
0.8471 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8471 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8293 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8291 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8232 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8224 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8188 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8176 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8129 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8098 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8052 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8041 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7987 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7976 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7961 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7914 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7914 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7901 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7898 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7895 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD2800 |
Approved |
0.787 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7862 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7849 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7849 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7848 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7848 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7848 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7843 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7841 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7824 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7821 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7811 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7792 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7792 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7792 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7792 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7792 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7791 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.777 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7765 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7736 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7733 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7727 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7674 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7674 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7661 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7654 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD1243 |
Approved |
0.764 |
Intermediate Similarity |
NPD920 |
Approved |
0.7636 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD943 |
Approved |
0.7576 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7564 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7547 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7546 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7531 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7473 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7473 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7419 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7419 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7418 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7418 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7416 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7362 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7326 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7312 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7305 |
Intermediate Similarity |
NPD37 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD919 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7263 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.724 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7238 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7237 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7222 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7188 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7176 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7168 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7166 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7162 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7105 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7102 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7078 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7051
|
Intermediate Similarity |
NPD4625 |
Phase 3 |